Cargando…

STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells

STAG2, an important subunit in cohesion complex, is involved in the segregation of chromosomes during the late mitosis and the formation of sister chromatids. Mutational inactivation of STAG2 is a major cause of the resistance of BRAF-mutant melanomas to BRAF/MEK inhibitors. In the present study, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xinru, Liu, Yan, Liu, Juan, Qiang, Wei, Ma, Jingjing, Xie, Jingyi, Chen, Pu, Wang, Yubo, Hou, Peng, Ji, Meiju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361981/ https://www.ncbi.nlm.nih.gov/pubmed/37479689 http://dx.doi.org/10.1038/s41419-023-05981-z

Ejemplares similares

Disulfiram/Cu Kills and Sensitizes BRAF-Mutant Thyroid Cancer Cells to BRAF Kinase Inhibitor by ROS-Dependently Relieving Feedback Activation of MAPK/ERK and PI3K/AKT Pathways
por: Xie, Jingyi, et al.
Publicado: (2023)

Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma
por: Shen, Che-Hung, et al.
Publicado: (2016)

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
por: Balbás-Martínez, Cristina, et al.
Publicado: (2013)

STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming
por: Chu, Zhaowei, et al.
Publicado: (2022)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene
por: Djos, Anna, et al.
Publicado: (2013)

Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAF(V600E)-driven human cancers
por: Wu, Yongxing, et al.
Publicado: (2021)

Different NIPBL requirements of cohesin-STAG1 and cohesin-STAG2
por: Alonso-Gil, Dácil, et al.
Publicado: (2023)

STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers
por: van der Lelij, Petra, et al.
Publicado: (2020)

CYP2S1 is a synthetic lethal target in BRAF(V600E)-driven thyroid cancers
por: Li, Yiqi, et al.
Publicado: (2020)

Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism
por: Michalak, Krzysztof Piotr, et al.
Publicado: (2015)

Distinct and overlapping roles of STAG1 and STAG2 in cohesin localization and gene expression in embryonic stem cells
por: Arruda, Nicole L., et al.
Publicado: (2020)

Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1
por: Benedetti, Lorena, et al.
Publicado: (2017)

Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts
por: van der Lelij, Petra, et al.
Publicado: (2017)

Cohesin Components Stag1 and Stag2 Differentially Influence Haematopoietic Mesoderm Development in Zebrafish Embryos
por: Ketharnathan, Sarada, et al.
Publicado: (2020)

Hashimoto’s Thyroiditis Minimizes Lymph Node Metastasis in BRAF Mutant Papillary Thyroid Carcinomas
por: Issa, Peter P., et al.
Publicado: (2022)

Tissue-specific reprogramming of glutamine metabolism maintains tolerance to sepsis
por: Leitner, Brooks P., et al.
Publicado: (2023)

Intuition and Deliberation in the Stag Hunt Game
por: Belloc, Marianna, et al.
Publicado: (2019)

Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
por: Baenke, Franziska, et al.
Publicado: (2015)

BET inhibition prevents aberrant RUNX1 and ERG transcription in STAG2 mutant leukaemia cells
por: Antony, Jisha, et al.
Publicado: (2020)

Clinical significance of immunohistochemistry to detect BRAF V600E mutant protein in thyroid tissues
por: Zhang, Yini, et al.
Publicado: (2021)

Glucocorticoid deficiency causes transcriptional and post-transcriptional reprogramming of glutamine metabolism
por: Weger, Meltem, et al.
Publicado: (2018)

Glutamine/glutamate metabolism rewiring in reprogrammed human hepatocyte-like cells
por: Ballester, Maria, et al.
Publicado: (2019)

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
por: Ma, Guofeng, et al.
Publicado: (2022)

T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade
por: Lee, Kyungho, et al.
Publicado: (2023)

VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer
por: Chen, Shitu, et al.
Publicado: (2020)

Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
por: Guo, Jing, et al.
Publicado: (2021)

MRI-Based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma
por: Zheng, Tingting, et al.
Publicado: (2023)

Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
por: Crespo-Rodriguez, Eva, et al.
Publicado: (2020)

BRAF-mutant hematopoietic malignancies
por: Abdel-Wahab, Omar, et al.
Publicado: (2014)

Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth
por: Cox, Andrew G., et al.
Publicado: (2016)

Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
por: Hao, Yujun, et al.
Publicado: (2016)

CBMS-1 TARGETING GLUTAMINE METABOLISM IN IDH-MUTANT GLIOMAS
por: Ohba, Shigeo, et al.
Publicado: (2022)

Nuclear Import and Export Signals of Human Cohesins SA1/STAG1 and SA2/STAG2 Expressed in Saccharomyces cerevisiae
por: Tarnowski, Leszek J., et al.
Publicado: (2012)

A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers
por: Mondal, Gourish, et al.
Publicado: (2019)

Expression of glutamine metabolism-related proteins in thyroid cancer
por: Kim, Hye Min, et al.
Publicado: (2016)

Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
por: Hernandez-Davies, Jenny E, et al.
Publicado: (2015)

Procedure for hiring STAG interns (short-term) in Smartrecruiters
por: Cook, Anna
Publicado: (2018)

Frequent truncating mutations of STAG2 in bladder cancer
por: Solomon, David A., et al.
Publicado: (2013)

STAG2 promotes the myelination transcriptional program in oligodendrocytes
por: Cheng, Ningyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1e1nbqv8tfq3unm1jeie80g2c9